Ferroptosis in neonatal and paediatric disease: From molecular mechanism to therapeutic target.
A prioritized translational framework that focuses on juvenile animal models, age-stratified pharmacokinetics, and patient-derived organoids is proposed to provide guidance for translating clinical practice to this vulnerable population of children.